Inventaire - your friends and communities are your best library - Inventaire

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

published in: Nature Cell Biology

date of publication: 2001-04-01

main subject: NF-κB, apoptotic process

Cites articles 45

Date

Title

Authors

2000-04-01

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).
2000-04-01

Role of NF-kappaB in p53-mediated programmed cell death

Kevin M Ryan
2000-03-01

HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway
2000-09-01

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

Michael J May
1999-07-01

Safety and antitumor activity of recombinant soluble Apo2 ligand
1999-02-01

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo

Jcl Schuh
1999-02-15

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis
1999-09

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis
1999-03-01

A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death
1998-08-01

A matter of life and cell death
1998-08-28

Caspases: enemies within
1998-08-28

Death receptors: signaling and modulation
1998-03-06

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling
1998-01-01

Expression of constitutively active IkappaB beta in T cells of transgenic mice: persistent NF-kappaB activity is required for T-cell immune responses
1998-09-11

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
1998-11-20

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

Bert Vogelstein, Kenneth W Kinzler, John M. Sedivy
1998-11-05

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta
1997-04-04

The receptor for the cytotoxic ligand TRAIL
1997-08-08

An antagonist decoy receptor and a death domain-containing receptor for TRAIL
1997-08-08

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
1997-09-01

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Mariapia A Degli-Esposti
1997-10-01

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

Wafik El-Deiry
1997-10-27

Characterization of two receptors for TRAIL

Jürg Tschopp
1997-12

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway
1997-09-01

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

Gavin R Screaton
1997-10-01

On the TRAIL from p53 to apoptosis?
1997-10-06

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

Henning Walczak, Mariapia A Degli-Esposti
1997-12

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

Mariapia A Degli-Esposti
1997-01-01

Janus faces of NF-kappa B: neurodestruction versus neuroprotection
1997-11-01

c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition
1997-12-01

Conversion of Bcl-2 to a Bax-like death effector by caspases
1996-05-31

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

Article - wd:Q73704115

Welcome to Inventaire

the library of your friends and communities

you are offline